Abstract PR05: A genetic variant at 6q25 associated with estrogen receptor-negative breast cancer subtypes in Peruvian breast cancer patients
Katie M. Marker(Berkeley College), Laura Fejerman(University of California, San Francisco), Tatiana Vidaurre(The University of Texas MD Anderson Cancer Center), Sikai Song(San Francisco General Hospital), Homero Fuentes(Instituto Nacional de Enfermedades Neoplásicas), Henry Gómez(National Cancer Center), Renzo Meza Florez(Instituto Nacional de Enfermedades Neoplásicas), Jeannie Navarro Vásquez(Instituto Nacional de Enfermedades Neoplásicas), Elad Ziv(University of California, San Francisco), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Julio E. Abugattas(City of Hope), Daniel Cherry(University of San Diego), Scott Huntsman(University of California, San Francisco), Donglei Hu(University of California, San Francisco), Mónica Calderón(Instituto Nacional de Enfermedades Neoplásicas), Lizeth I. Tamayo(University of Illinois Chicago)
Cited by 0
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis
|The American Journal of Human Genetics|2016|921
The Immune Landscape of Cancer
|Immunity|2019|806
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684